Non-reduction in hippocampal volume is associated with higher risk of psychosis

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 145-158

  Phillips, Lisa J ^a   Velakoulis, Dennis ^a   Pantelis, Christos ^a   Wood, Stephen ^a   Yuen, Hok Pan ^a   Yung, Alison R ^b   Desmond, Patricia ^b   Brewer, Warrick ^a   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Mental Health Research Institute ^*  (Australia)

Author keywords

High risk; Hippocampus; MRI scans; Prediction; Psychosis

Indexed keywords

ADULT; ARTICLE; BRAIN DEVELOPMENT; BRAIN SIZE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA;

ACUTE DISEASE; ADULT; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 0036888757     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00392-9     Document Type: Article

References (97)

1. Altshuler L.L., Bartzokis G., Greider T., Curran J., Jiminez T., Leight K., Wilkins J., Gerner R., Mintz J. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol. Psychiatry. 48:2000;147-162.
2. Andreasen N.C., Flaum M., Arndt S. The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry. 49:1992;615-623.
3. Arnold S.E. Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology. Dev. Psychopathol. 11:1999;439-456.
4. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders. 1994;American Psychiatric Association, Washington.
5. Becker T., Elmer K., Schenider F., Schneider M., Grodd W., Bartels M., Heckers S., Beckmann H. Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia. Psychiatry Res.: Neuroimaging. 67:1996;135-143.
6. Bell R.Q. Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry. 55:1992;370-381.
7. Benes F.M., Sorensen I., Bird E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr. Bull. 17:1991;597-608.
8. Birchwood M. Early intervention in schizophrenia: theoretical background and clinical strategies. Br. J. Clin. Psychol. 31:1992;257-278.
9. Blackwood D.H., Young A.H., McQueen J.K., Martin M.J., Roxborough H.M., Muir W.J., St Clair D.M., Kean D.M. Magnetic resonance imaging in schizophrenia: altered brain morphology associated with P300 abnormalities and eye tracking dysfunction. Biol. Psychiatry. 30:1991;753-769.
10. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr. Bull. 19:1993;431-445.
11. Bogerts B., Ashtari M., Degreef G., Alvir J.M. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res.: Neuroimaging. 35:1990;1-13.
12. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic, pre-frontal cortex and caudate structures. Arch. Gen. Psychiatry. 49:1992;921-926.
13. Cannon T.D., Mednick S.A. The schizophrenia high-risk project in Copenhagen: three decades of progress. Acta Psychiatrica Scand. 87:1993;33-47.
14. Cannon T.D., Mednick S.A., Parnas J., Schulsinger F., Praestholm J., Vestergaard A. Developmental brain abnormalities in the offspring of schizophrenic mothers I: contributions of genetic and perinatal factors. Arch. Gen. Psychiatry. 50:1993;551-564.
15. Cannon T.D., van Erp T.G., Huttunen M., Lonnqvist J., Salonen O., Valanne L., Poutanen V.P., Standertskjold-Nordenstam C.G., Gur R.E., Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry. 55:1998;1084-1091.
16. Dauphinais I.D., DeLisi L.E., Crow T.J., Alexandropolous K., Colter N., Tuma I., Gerson E.S. Reduction in temporal lobe size in siblings with schizophrenia: a magnetic resonance imaging study. Psychiatry Res. 35:1990;137-147.
17. DeLisi L.E., Dauphinais I.D., Gershon E.S. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophr. Bull. 14:1988;185-191.
18. DeLisi L.E., Strizke P.H., Holan V., Anand A., Boccio A., Kuschner M., Riordan H., McClelland J., Van Eyle O. Brian morphological changes in 1st episode cases of schizophrenia: are they progressive? Schizophr. Res. 5:1991;206-208.
19. DeLisi L.E., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M., Grimson R. A prospective follow-up study of brain morphology and cognition in first episode schizophrenia patients: preliminary findings. Biol. Psychiatry. 38:1995;349-360.
20. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 74:1997;129-140.
21. Flaum M., Swayze V.W., O'Leary D.S., Yuh W.T.C., Ehrhardt J.C., Arndt S.V., Andreasen N.C. Effects of diagnosis, laterality and gender on brain morphology in schizophrenia. Am. J. Psychiatry. 152:1995;704-714.
22. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient edition (SCID-I/P, Version 2.0). 1996;New York State Psychiatric Institute, New York.
23. Fukuzako H., Kodama S., Fukazako T., Yanada K., Hokazono Y., Ueyama K., Hashiguchi K., Takenouchi K., Takigawa M., Takeuchi K. Shortening of the hippocampal formation in first-episode schizophrenic patients. Psychiatry Clin. Neurosci. 49:1995;157-161.
24. Fukuzako H., Fukuzako T., Hashiguchi T., Hokazono Y., Takeuchi K., Hirakawa K., Ueyama K., Takigawa M., Kajiya Y., Nakajo M., Fujimoto T. Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: assessment by MRI. Biol. Psychiatry. 39:1996;938-945.
25. Geddes J.R., Lawrie S.M. Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. J. Psychiatr. Res. 21:1995;413-421.
26. Giedd J.N., Jeffries N.O., Blumenthal J., Castellanos F.X., Vaituzis A.C., Fernandez T., Hamburger S.D., Liu H., Nelson J., Bedwell J., Tran L., Lenane M., Nicolson R., Rapoport J. Childhood onset schizophrenia: progressive brain changes during adolescence. Biol. Psychiatry. 46:1999;892-898.
27. Gold J.M., Harvey P.D. Cognitive deficits in schizophrenia. Psychiatr. Clin. North Am. 16:1993;295-312.
28. Goldman-Rakic P.S. Prefrontal cortex dysfunction in schizophrenia: the relevance of working memory. Carroll B., Barrett J. Psychopathology and the Brain. 1990;1-23 Raven Press, New York.
29. Gur R.E., Cowell P., Turtsky B.I., Gallacher F., Cannon T., Bilker W., Gur R.C. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry. 55:1998;145-152.
30. Gur R.E., Turetsky B.I., Cowell P.E., Finkelman C., Maany V., Grossman R.J., Arnold S.E., Bilker W.B., Gur R.C. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry. 57:2000;769-775.
31. Harrison P.J. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 122:1999;593-624.
32. Henn F.A., Braus D.F. Structural neuroimaging in schizophrenia: an integrative view of neuromorphology. Eur. Arch. Psychiatry Clin. Neurosci. 249(Suppl. 4):1999;48-56.
33. Hirayasu Y., Shenton M.E., Saisbury D.F., Dickey C.C., Fischer I.A., Mazzoni P., Kisler T., Arakaki H., Soo Kwon J., Anderson J.E., Yurgelun-Todd D., Tohen M., McCarley R.W. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am. J. Psychiatry. 155:1998;1384-1391.
34. Hoff A.L., Riordan H., O'Donnell D., Stritzke P., Neale C., Boceio A., Anand A.K., DeLisi L.E. Anamolous lateral sulcus asymmetry and cognitive function in first episode schizophrenia. Schizophr. Bull. 18:1992;257-272.
35. Hutton S.B., Puri B.K., Duncan L.J., Robbins T.W., Barnes T.R., Joyce E.M. Executive function in first-episode schizophrenia. Psychol. Med. 28:1998;463-473.
36. Jacobsen L.K., Giedd J.N., Vaituzis A.C., Hamburger S.D., Rajapakse J.C., Frazier J.A., Kaysem D., Lenane M.C., McKenna K., Gordon C.T., Rapoport J.L. Temporal lobe morphology in childhood-onset schizophrenia. Am. J. Psychiatry. 153:1996;355-361.
37. Kawasaki Y., Maeda Y., Urata K., Higashima M., Yamaguchi N., Suzuki M., Takashima T., Ide Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 242:1993;268-272.
38. Kegeles L.S., Shungu D.C., Anjivel S., Chan S., Ellis S.P., Xanthopoulos E., Malaspina D., Gorman J.M., Mann J.J., Laruelle M., Kaufmann C.A. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res.: Neuroimaging. 98:2000;163-175.
39. Kelsoe J.R., Cadet J.L., Pickar D., Weinberger D.R. Quantitative neuroanatomy in schizophrenia: a controlled magnetic resonance imaging study. Arch. Gen. Psychiatry. 45:1988;533-541.
40. Keshaven M.S., Montrose D.M., Pierri J.N., Dick E.L., Rosenberg D., Talagala L., Sweeney J.A. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 21:1997;1285-1295.
41. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B. Jr., Charney D.S. Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry. 51:1994;199-214.
42. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 172:1998;110-120.
43. Lawrie S.M., Whalley H., Kestelman J.N., Abukmeil S.S., Byrne M., Hodges A., Rimmington J.E., Best J.J.K., Owens D.G.C., Johnstone E.C. Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet. 353:1999;30-33.
44. Lieberman J.A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry. 46:1999;729-739.
45. Lieberman J.A. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia. J. Clin. Psychiatry. 60(Suppl. 12):1999;9-12.
46. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 147:1997;205-229.
47. Marsh L., Harris D., Lim K.O., Beal M., Hoff A.L., Minn K., Csernansky J.G., Dement S., Faustman W.O., Sullivan E.V., Pfefferbaum A. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at onset. Arch. Gen. Psychiatry. 54:1997;1104-1112.
48. MathSoft S-PLUS for Windows. 1997;. Seattle, WA.
49. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol. Psychiatry. 45:1999;1085-1098.
50. McGlashan T.H., Johanssen J.O. Early detection and intervention with schizophrenia: rationale. Schizophr. Bull. 22:1996;201-222.
51. McGorry P.D. 'A stitch in time...' the scope for preventive strategies in early psychosis. Eur. Arch. Psychiatry Clin. Neurosci. 248:1998;22-31.
52. McGorry P.D., Jackson H.J. Recognition and Management of Early Psychosis. 1999;Cambridge University Press, New York.
53. McGorry P.D., Singh B.S. Schizophrenia: risk and possibility. Raphael B., Burrows G.D. Handbook of Studies on Preventive Psychiatry. 1995;491-514 Elsevier, Amsterdam.
54. McGorry P.D., Phillips L.J., Yung A.R. Recognition and treatment of the pre-psychotic phase of psychotic disorders: frontier or fantasy? Miller T., Mednick S.A., McGlashan T.H., Libiger J., Johannessen J.O. Early Intervention in Psychiatric Disorders. 2001;101-122 Kluwer, Netherlands.
55. McGorry P.D., Yung A.R., Phillips L.J. 'Closing in': what features predict the onset of first episode psychosis within a high risk group? Zipursky R.B. The Early Stages of Schizophrenia. 2001;3-32 American Psychiatric Press, Washington.
56. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., Partanen J., Tiihonen J., Viinamaki H., Karjalainen A.K., Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol. Med. 30:2000;117-125.
57. Mockler D., Riordan J., Sharma T. Memory and intellectual deficits do not decline with age in schizophrenia. Schizophr. Res. 26:1997;1-7.
58. Nelson H.E., Willison J.R. The Revised National Adult Reading Test - Test Manual. 1991;NFER, Windsor, UK.
59. Niemann K., Hammers A., Coenen V.A., Thron A., Klosterkötter J. Evidence of a smaller left hippocampus and left temporal horn in patients with first episode schizophrenia and normal control subjects. Psychiatry Res.: Neuroimaging. 99:2000;93-110.
60. O'Brien J.T. The 'glucocorticoid cascade' hypothesis in man. Br. J. Psychiatry. 170:1997;199-201.
61. Olney J., Farber N. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
62. Pantelis C., Barber F.Z., Barnes T.R., Nelson H.E., Owen A.M., Robbins T.W. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr. Res. 37:1999;251-270.
63. Pantelis C., Velakoulis D., Suckling J., McGorry P., Phillips L., Yung A., Wood S., Bullmore E., Brewer W., Soulsby B., McGuire P. Left medial temporal volume reduction occurs during the transition from high risk to first-episode psychosis. Schizophr. Res. 41:2000;35.
64. Pantelis C., Yucel M., Wood S.J., McGorry P.D., Velakoulis D. The timing and functional consequences of structural brain abnormalities in schizophrenia. NeuroSci News. 4:2001;36-46.
65. Parmar M.K.B., Machin D. Survival Analysis: A Practical Approach. 1995;Wiley, Chichester.
66. Phillips L.J., Yung A.R., Hearn N., McFarlane C.A., Hallgren M., McGorry P.D. Preventive mental health care: accessing the target population. Aust. N. Z. J. Psychiatry. 33:1999;912-917.
67. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a post-mortem morphometric study of schizophrenia and Huntington's disease. Arch. Gen. Psychiatry. 55:1998;215-224.
68. Rapoport J.L., Giedd J., Kumra S., Jacobsen L., Smith A., Lee P., Nelson J. Childhood onset schizophrenia: progressive ventricular enlargement during adolescence on MRI brain rescan. Arch. Gen. Psychiatry. 54:1997;897-903.
69. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., Evans A. Progressive cortical change during adolescence in childhood onset schizophrenia: a longitudinal MRI study. Arch. Gen. Psychiatry. 56:1999;649-654.
70. Rossi A., Stratta P., Mancini F., Gallucci M., Mattei P., Core L., Di Michele V., Casacchia M. Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinking in male patients with schizophrenia. Psychiatry Res. 52:1994;43-53.
71. Sanfilipo M., Larfargue T., Rusinek H., Arena L., Loneragan C., Lautin A., Feiner D., Rotrosen J., Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry. 57:2000;471-480.
72. Seidman L.J., Faraone S.V., Foldstein J.M., Goodman J.M., Kreman W.S., Matsuda G., Hoge E.A., Kennedy D., Makris N., Caviness V.S., Tsuang M.T. Reduced subcortical brain volumes in nonpsychotic siblings of schizophrenic patients: a pilot magnetic resonance imaging study. Am. J. Med. Genet. 74:1997;507-514.
73. Shapiro R.M. Regional neuropathology in schizophrenia: where are we? Where are we going? Schizophr. Res. 10:1993;187-239.
74. Sharma T., Lancaster E., Sigmundsson T., Lewis S., Takei N., Gurling H., Barta P., Pearlson G., Murray R. Lack of normal pattern of cerebral asymmetry in familial schizophrenic patiens and their relatives - the Maudsley Family Study. Schizophr. Res. 40:1999;111-120.
75. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McCarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitive magnetic resonance imaging study. New Engl. J. Med. 327:1992;604-612.
76. SPSS SPSS for Windows (Version 8.0). 1998;SPSS Inc. Chicago, IL.
77. Staal W.G., Hulshoff Pol H.E., Schnack H., van der Schot A.C., Kahn R.S. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. Am. J. Psychiatry. 155:1998;1784-1786.
78. Stefanis N., Frangou S., Yakeley J., Sharma T., O'Connell P., Morgan K., Sigmudsson T., Taylor M., Murray R. Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biol. Psychiatry. 46:1999;697-702.
79. Suddath R.L., Casanova M.F., Goldberg T.E., Daniel D.G., Kelsoe J.R., Weinberger D.R. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am. J. Psychiatry. 146:1989;464-472.
80. Suddath R.L., Christison G.W., Torrey E.F., Casanova M.F., Weinberger D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New Engl. J. Med. 322:1990;789-794.
81. Swayze V.W., Andreasen N.C., Alliger R.J., Yuh W.T., Ehrhardt J.C. Subcortical and temporal structures in affective disorder and schizophrenia: a controlled magnetic resonance imaging study. Biol. Psychiatry. 31:1992;221-240.
82. Torres I.J., Flashman L.A., O'Leary D.S., Swayze V., Andreasen N.C. Lack of an association between delayed memory and hippocampal and temporal lobe size in patients with schizophrenia and healthy controls. Biol. Psychiatry. 42:1997;1087-1096.
83. Tracy J.I., McGrory A.C., Josiassen R.C., Monaco C.A. A comparison of reading and demographic-based estimates of premorbid intelligence in schizophrenia. Schizophr. Res. 22:1996;103-109.
84. Vakili K., Pillay S.S., Lafer B., Fava M., Renshaw P.F., Bonello-Cintron C.M., Yurgelun-Todd D.A. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol. Psychiatry. 47:2000;1087-1090.
85. Velakoulis D., Pantelis C., McGorry P.D., Dudgeon P., Brewer W., Cook M., Desmond P., Bridle N., Tierney P., Murrie V., Singh B., Copolov D. Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high resolution Magnetic Resonance Imaging study. Arch. Gen. Psychiatry. 56:1999;133-140.
86. Velakoulis D., Wood S.J., McGorry P.D., Pantelis C. Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust. N. Z. J. Psychiatry. 34(Suppl.):2000;S113-S126.
87. Vita A., Dieci M., Giobbio G.M., Garbarini M., Morganti C., Braga M., Invernizzi G.S.O. A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. Psychiatry Res. 53:1994;41-55.
88. Weinberger D.E. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
89. Weinberger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
90. Weinberger D.R., DeLisi L.E., Neophytides A.N., Wyatt R.J. Familial aspects of CT scan abnormalities in chronic schizophrenic patients. Psychiatry Res. 4:1981;65-71.
91. Whitworth A.B., Honeder M., Kremser C., Kemmler G., Felber S., Hausmann A., Wanko C., Wechdorn H., Aichner F., Stuppaeck C.H., Fleischhacker W.W. Hippocampal volume reduction in male schizophrenic patients. Schizophr. Res. 31:1998;73-81.
92. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670.
93. Young A.H., Blackwood D.H.R., Roxborough H., McQueen J.K., Martin M.J., Kean D. A magnetic resonance imaging study of schizophrenia: brain structure and clinical symptoms. Br. J. Psychiatry. 158:1991;158-164.
94. Yung A.R., McGorry P.D., McFarlane C.A., Jackson H.J., Patton G.C., Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr. Bull. 22:1996;283-303.
95. Yung A.R., Phillips L.J., McGorry P.D., Hallgren M.A., McFarlane C.A., Jackson H.J., Francey S., Patton G.C. Can we predict onset of first episode psychosis in a high risk group? Int. Clin. Psychopharmacol. 13:1998;S23-S30.
96. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Francey, S.F., McFarlane, C.A., in press. Psychosis prediction: 12 month follow-up of a high risk ('prodromal') group. Schizophr. Res.
97. Zipursky R.B., Marsh L., Lim K.O., Dement S., Shear P.K., Sullivan E.V., Murphy G.M., Csernensky J.G., Pfefferbaum A. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol. Psychiatry. 35:1994;501-516.